Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REST-ON: FT218 in Narcolepsy
NCT02720744Phase 3Completed
- Sponsor
- Avadel Pharmaceuticals
- Start
- Nov 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of sodium oxybate in narcolepsy, sponsored by Avadel Pharmaceuticals. Started Nov 2016; status: completed.
02
Drugs
sodium oxybate
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT02720744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02720744.